Try

Genmab A/S

GMABUnited States

14 filed reports · 406 financial concepts · 2 earnings calls · 0 media appearances

Filed reports

14 reports · Dec 2019 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 2 guidance figures, 282 interim figures.

Report typeReportsFactsPeriods
Interim · 6-KSEC EDGAR122,245Jun 2021 to Jun 2026
Annual · 20-FSEC EDGAR21,342Dec 2019 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q26-KJun 30, 2026Aug 6, 2026321Open
FY2026 Q26-KJun 30, 2026Aug 6, 202610Open
FY202520-FDec 31, 2025Feb 17, 2026796Open
FY2025 Q26-KJun 30, 2025Aug 7, 2025125Open
FY2025 Q26-KJun 30, 2025Aug 7, 20252Open
FY2024 Q46-KDec 31, 2024Feb 12, 2025570Open
FY2024 Q26-KJun 30, 2024Aug 8, 2024128Open
FY2023 Q46-KDec 31, 2023Feb 14, 2024296Open
FY2023 Q26-KJun 30, 2023Aug 3, 202385Open
FY2022 Q46-KDec 31, 2022Feb 22, 2023235Open
FY2022 Q26-KJun 30, 2022Aug 10, 202287Open
FY2021 Q46-KDec 31, 2021Feb 16, 2022287Open

Financial data

406 concepts · 3,587 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial403 concepts · 3,556 facts · Dec 2014 to Jun 2026

  • Total56 · Dec 2016 to Dec 2025
  • Issued capital38 · Dec 2014 to Jun 2026
  • Cash and cash equivalents34 · Dec 2016 to Jun 2026
  • Equity34 · Dec 2016 to Jun 2026
  • Cash (IFRS)29 · Dec 2017 to Dec 2025
  • Revenue29 · Dec 2017 to Jun 2026
  • Marketable securities27 · Dec 2018 to Dec 2025
  • Assets (IFRS)26 · Dec 2018 to Jun 2026
  • Contingent commitments26 · Dec 2018 to Dec 2025
  • Current assets26 · Dec 2018 to Jun 2026
  • Current liabilities26 · Dec 2018 to Jun 2026
  • Equity and liabilities26 · Dec 2018 to Jun 2026
  • Intangible assets other than goodwill26 · Dec 2018 to Jun 2026
  • Liabilities (IFRS)26 · Dec 2018 to Jun 2026
  • Noncurrent assets (IFRS)26 · Dec 2018 to Jun 2026
  • Noncurrent liabilities26 · Dec 2018 to Jun 2026
  • Noncurrent receivables (IFRS)26 · Dec 2018 to Jun 2026
  • Other current payables26 · Dec 2018 to Jun 2026
  • Other noncurrent payables (IFRS)26 · Dec 2018 to Jun 2026
  • Other reserves (IFRS)26 · Dec 2018 to Jun 2026
  • Property plant and equipment26 · Dec 2018 to Jun 2026
  • Retained earnings26 · Dec 2018 to Jun 2026
  • Rightofuse assets26 · Dec 2019 to Jun 2026
  • Share premium (IFRS)26 · Dec 2018 to Jun 2026

Geography1 concepts · 27 facts · Dec 2017 to Dec 2025

  • Revenue27 · Dec 2017 to Dec 2025

Guidance2 concepts · 4 facts · Aug 2026

  • Operating Income Guidance2 · Aug 2026
  • Revenue Guidance2 · Aug 2026

Segments

27 facts

Figures broken down by business line, region, product or another axis the company reports on.

Geographical areas5 members · 27 facts

  • DK11 · Dec 2017 to Dec 2025
  • JP5 · Dec 2023 to Dec 2025
  • US5 · Dec 2023 to Dec 2025
  • CN3 · Dec 2023 to Dec 2025
  • NL3 · Dec 2023 to Dec 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Management discussion (MD&A) commentary39 claims from 2 reports · Dec 2024 to Dec 2025
  • Risk-factor changes24 claims from 1 reports · Dec 2025
  • Risk factors103 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · May 2026 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 6, 2026
  • FY2026 Q1May 6, 2026

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Genmab A/S (GMAB) data · FactIQ